04/04/2023
Anne OâNeill saw brilliant Australian medical innovations lost to overseas interests that were willing to get them to market. So, she set up a means of mentoring researchers and connecting them with industry and government funding to keep them here.
âIâm at the nexus of championing things â research and innovations, such as revolutionary medical devices, that struggle to be translated commercially,â says OâNeill. âIn part, itâs about accelerating and de-risking the process. Until recently, the commercialisation and de-risking processes had been done offshore.â
OâNeill stresses that, in Australian health and medical research, particularly in the health system and public research organisations, there has been a struggle to work effectively with industry, or even to make the connection.
âThe health system is cautious about being seen as unduly influenced or tainted by industry,â says OâNeill. âSo, when it comes to funding research, there is immense pressure on scientists and researchers to be seen as objective and impartial and they are therefore hesitant to engage industry support.â
âBecause of this, we have lost Australian innovations to overseas interests that are willing to get them to market,â says OâNeill. âThis means we have lost a significant return on investment, not only to governments that supported the initial research, but to the Australian population.â
Read her brilliant story
https://thebrilliant.com.au/profiles/anne-oneill/